Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Politics

FDA chief counsel who defended abortion pill access under Biden resigns two days into job

by March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill access under Biden resigns two days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to HHS and FDA for comment.

This is a breaking story. Check back for updates.

This post appeared first on FOX NEWS
previous post
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job
next post
White House pulls nomination of David Weldon as CDC director

Related Posts

Venezuelan prosecutor seeks arrest warrant for opposition’s former...

September 3, 2024

House Dems ‘very open’ to saving Johnson speakership...

April 18, 2024

Durbin obstruction threat chills Senate as Trump nominees...

June 4, 2025

‘Take a seat’: Obama ripped for being on...

December 7, 2024

Pope Francis urges Catholic voters to ‘choose the...

September 14, 2024

Israel considers preemptive strike on Iran as tensions...

August 5, 2024

Trump allies turn up the heat on GOP...

December 12, 2024

Federal judge delays unions’ request to block DOGE...

February 15, 2025

Hawley says muzzled Meta whistleblower will testify over...

April 3, 2025

HHS axes more than $300M in gender, DEI-related...

March 27, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • Trump’s CDC pick confirmed—but her pro-vaccine stance may clash with RFK Jr.’s agenda

      July 29, 2025
    • Union Pacific to buy Norfolk in $85 billion mega U.S. railroad deal

      July 29, 2025
    • ‘Critical’ closed-door congressional huddle focuses on growing antisemitism in US, Mamdani’s rise

      July 29, 2025
    • Starmer says UK to recognize Palestinian state if Israel doesn’t agree to ceasefire, Hamas must ‘disarm’

      July 29, 2025
    • North Korea breaks silence on Trump’s return, sends message from ‘Rocket Man’

      July 29, 2025
    • Mamdani’s rise, ‘vile hatred’ of US Jews the focus of ‘critical’ closed-door congressional huddle

      July 29, 2025

    Categories

    • Business (1,325)
    • Politics (6,586)
    • Stocks (904)
    • World News (461)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved